The global market for EO Residual Testing was valued at US$ 2486 million in the year 2023 and is projected to reach a revised size of US$ 4084 million by 2030, growing at a CAGR of 7.4% during the forecast period.
EO Residual Testing, also known as Ethylene Oxide Residual Testing, is a crucial analytical process used to detect and quantify the remaining amounts of ethylene oxide (EO) on or within a product following its exposure to ethylene oxide gas during sterilization or other related processes. Given that ethylene oxide is a potent and potentially hazardous chemical, this testing is essential in industries like medical device manufacturing, pharmaceuticals, and food processing to ensure product safety. It precisely determines the level of EO residuals, as excessive amounts can pose risks to human health, including irritation, sensitization, and potential carcinogenic effects.
North American market for EO Residual Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for EO Residual Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for EO Residual Testing in Pharmaceuticals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of EO Residual Testing include Eurofins Scientific, Nelson Labs, Steris, JordiLabs, LLC, TÃœV SÃœD, UFAG LABORATORIEN AG, Europejski Instytut Biomedyczny, SaniChem, Millstone Medical, Medistri, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for EO Residual Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding EO Residual Testing.
The EO Residual Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global EO Residual Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the EO Residual Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eurofins Scientific
Nelson Labs
Steris
JordiLabs, LLC
TÃœV SÃœD
UFAG LABORATORIEN AG
Europejski Instytut Biomedyczny
SaniChem
Millstone Medical
Medistri
Auriga Research
Pace Analytical
STEMart
MCI
Segment by Type
Brief Contact（up to 24 Hour）
Long Term Contact（more than 1 Days）
Segment by Application
Pharmaceuticals
Medical Devices
Food Products
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of EO Residual Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global EO Residual Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Brief Contact（up to 24 Hour）
1.2.3 Long Term Contact（more than 1 Days）
1.3 Market by Application
1.3.1 Global EO Residual Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceuticals
1.3.3 Medical Devices
1.3.4 Food Products
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global EO Residual Testing Market Perspective (2019-2030)
2.2 Global EO Residual Testing Growth Trends by Region
2.2.1 Global EO Residual Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 EO Residual Testing Historic Market Size by Region (2019-2024)
2.2.3 EO Residual Testing Forecasted Market Size by Region (2025-2030)
2.3 EO Residual Testing Market Dynamics
2.3.1 EO Residual Testing Industry Trends
2.3.2 EO Residual Testing Market Drivers
2.3.3 EO Residual Testing Market Challenges
2.3.4 EO Residual Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top EO Residual Testing Players by Revenue
3.1.1 Global Top EO Residual Testing Players by Revenue (2019-2024)
3.1.2 Global EO Residual Testing Revenue Market Share by Players (2019-2024)
3.2 Global EO Residual Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by EO Residual Testing Revenue
3.4 Global EO Residual Testing Market Concentration Ratio
3.4.1 Global EO Residual Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by EO Residual Testing Revenue in 2023
3.5 Global Key Players of EO Residual Testing Head office and Area Served
3.6 Global Key Players of EO Residual Testing, Product and Application
3.7 Global Key Players of EO Residual Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 EO Residual Testing Breakdown Data by Type
4.1 Global EO Residual Testing Historic Market Size by Type (2019-2024)
4.2 Global EO Residual Testing Forecasted Market Size by Type (2025-2030)
5 EO Residual Testing Breakdown Data by Application
5.1 Global EO Residual Testing Historic Market Size by Application (2019-2024)
5.2 Global EO Residual Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America EO Residual Testing Market Size (2019-2030)
6.2 North America EO Residual Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America EO Residual Testing Market Size by Country (2019-2024)
6.4 North America EO Residual Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe EO Residual Testing Market Size (2019-2030)
7.2 Europe EO Residual Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe EO Residual Testing Market Size by Country (2019-2024)
7.4 Europe EO Residual Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific EO Residual Testing Market Size (2019-2030)
8.2 Asia-Pacific EO Residual Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific EO Residual Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific EO Residual Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America EO Residual Testing Market Size (2019-2030)
9.2 Latin America EO Residual Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America EO Residual Testing Market Size by Country (2019-2024)
9.4 Latin America EO Residual Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa EO Residual Testing Market Size (2019-2030)
10.2 Middle East & Africa EO Residual Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa EO Residual Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa EO Residual Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eurofins Scientific
11.1.1 Eurofins Scientific Company Details
11.1.2 Eurofins Scientific Business Overview
11.1.3 Eurofins Scientific EO Residual Testing Introduction
11.1.4 Eurofins Scientific Revenue in EO Residual Testing Business (2019-2024)
11.1.5 Eurofins Scientific Recent Development
11.2 Nelson Labs
11.2.1 Nelson Labs Company Details
11.2.2 Nelson Labs Business Overview
11.2.3 Nelson Labs EO Residual Testing Introduction
11.2.4 Nelson Labs Revenue in EO Residual Testing Business (2019-2024)
11.2.5 Nelson Labs Recent Development
11.3 Steris
11.3.1 Steris Company Details
11.3.2 Steris Business Overview
11.3.3 Steris EO Residual Testing Introduction
11.3.4 Steris Revenue in EO Residual Testing Business (2019-2024)
11.3.5 Steris Recent Development
11.4 JordiLabs, LLC
11.4.1 JordiLabs, LLC Company Details
11.4.2 JordiLabs, LLC Business Overview
11.4.3 JordiLabs, LLC EO Residual Testing Introduction
11.4.4 JordiLabs, LLC Revenue in EO Residual Testing Business (2019-2024)
11.4.5 JordiLabs, LLC Recent Development
11.5 TÃœV SÃœD
11.5.1 TÃœV SÃœD Company Details
11.5.2 TÃœV SÃœD Business Overview
11.5.3 TÃœV SÃœD EO Residual Testing Introduction
11.5.4 TÃœV SÃœD Revenue in EO Residual Testing Business (2019-2024)
11.5.5 TÃœV SÃœD Recent Development
11.6 UFAG LABORATORIEN AG
11.6.1 UFAG LABORATORIEN AG Company Details
11.6.2 UFAG LABORATORIEN AG Business Overview
11.6.3 UFAG LABORATORIEN AG EO Residual Testing Introduction
11.6.4 UFAG LABORATORIEN AG Revenue in EO Residual Testing Business (2019-2024)
11.6.5 UFAG LABORATORIEN AG Recent Development
11.7 Europejski Instytut Biomedyczny
11.7.1 Europejski Instytut Biomedyczny Company Details
11.7.2 Europejski Instytut Biomedyczny Business Overview
11.7.3 Europejski Instytut Biomedyczny EO Residual Testing Introduction
11.7.4 Europejski Instytut Biomedyczny Revenue in EO Residual Testing Business (2019-2024)
11.7.5 Europejski Instytut Biomedyczny Recent Development
11.8 SaniChem
11.8.1 SaniChem Company Details
11.8.2 SaniChem Business Overview
11.8.3 SaniChem EO Residual Testing Introduction
11.8.4 SaniChem Revenue in EO Residual Testing Business (2019-2024)
11.8.5 SaniChem Recent Development
11.9 Millstone Medical
11.9.1 Millstone Medical Company Details
11.9.2 Millstone Medical Business Overview
11.9.3 Millstone Medical EO Residual Testing Introduction
11.9.4 Millstone Medical Revenue in EO Residual Testing Business (2019-2024)
11.9.5 Millstone Medical Recent Development
11.10 Medistri
11.10.1 Medistri Company Details
11.10.2 Medistri Business Overview
11.10.3 Medistri EO Residual Testing Introduction
11.10.4 Medistri Revenue in EO Residual Testing Business (2019-2024)
11.10.5 Medistri Recent Development
11.11 Auriga Research
11.11.1 Auriga Research Company Details
11.11.2 Auriga Research Business Overview
11.11.3 Auriga Research EO Residual Testing Introduction
11.11.4 Auriga Research Revenue in EO Residual Testing Business (2019-2024)
11.11.5 Auriga Research Recent Development
11.12 Pace Analytical
11.12.1 Pace Analytical Company Details
11.12.2 Pace Analytical Business Overview
11.12.3 Pace Analytical EO Residual Testing Introduction
11.12.4 Pace Analytical Revenue in EO Residual Testing Business (2019-2024)
11.12.5 Pace Analytical Recent Development
11.13 STEMart
11.13.1 STEMart Company Details
11.13.2 STEMart Business Overview
11.13.3 STEMart EO Residual Testing Introduction
11.13.4 STEMart Revenue in EO Residual Testing Business (2019-2024)
11.13.5 STEMart Recent Development
11.14 MCI
11.14.1 MCI Company Details
11.14.2 MCI Business Overview
11.14.3 MCI EO Residual Testing Introduction
11.14.4 MCI Revenue in EO Residual Testing Business (2019-2024)
11.14.5 MCI Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Eurofins Scientific
Nelson Labs
Steris
JordiLabs, LLC
TÃœV SÃœD
UFAG LABORATORIEN AG
Europejski Instytut Biomedyczny
SaniChem
Millstone Medical
Medistri
Auriga Research
Pace Analytical
STEMart
MCI
Ìý
Ìý
*If Applicable.
